ADVERSE DRUG-REACTIONS LEADING TO HOSPITAL ADMISSION

被引:33
作者
IBANEZ, L [1 ]
LAPORTE, JR [1 ]
CARNE, X [1 ]
机构
[1] UNIV AUTONOMA BARCELONA,HOSP UNIV VALL DHEBRON,SERV FARMACOL CLIN,UNITAT FARMACOL CLIN,E-08035 BARCELONA,SPAIN
关键词
D O I
10.2165/00002018-199106060-00005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This article describes the implementation of a simple method of drug surveillance set up at a hospital emergency ward. From a total of 48 678 patients admitted, the medical records of those presenting with one or more of a pre-established list of admission diagnoses (n = 7728; 15.8%) were checked. Of these 554 (1.1%) were diagnosed as experiencing an adverse drug reaction. When the medical record suggested an adverse drug reaction, drugs taken before admission were ascertained by interviewing the patients with a structured questionnaire. After excluding upper gastrointestinal bleeding (226 cases) and certain bone marrow blood dyscrasias (42 cases), 286 patients with drug-induced events leading to hospital admission were identified in 2 years. Fatal adverse drug reactions, previously undescribed reactions, and some specific examples, such as digoxin-amiodarone interaction, drug-induced pancreatitis, nicardipine-induced AV block, severe skin reactions, and NSAID-induced bronchospasm, are described. Basically, this method consists of assembling series of cases systematically, and is therefore devoid of selective bias. In addition, it allows a more indepth clinical and anamnesic study of specific diseases, as compared with voluntary reporting.
引用
收藏
页码:450 / 459
页数:10
相关论文
共 45 条
[11]  
Elias P.M., Fritsch P.O., Erythema multiforme, Dermatology in general medicine, pp. 295-306, (1979)
[12]  
Goodfield H.J., Millard L.G., Severe cutaneous reactions to captopril, British Medical Journal, 290, (1985)
[13]  
Hodsman G.P., Robertson J.I.S., Captopril, five years on, British Medical Journal, 287, pp. 852-853, (1983)
[14]  
Ibanez L., Juan J., Perez E., Carne X., Laporte J.R., Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach, European Heart Journal, 12, pp. 639-641, (1991)
[15]  
Inman W.H.W., Rawson N.S.B., Wilton L.V., Prescription-event monitoring, Monitoring for drug safety, pp. 213-235, (1986)
[16]  
The design of a study of the drug etiology of agranulocytosis and aplastic anemia: a report from the International Agranulocytosis and Aplastic Anemia Study, European Journal of Clinical Pharmacology, 24, pp. 833-836, (1983)
[17]  
Karcn F.E., Lasagna L., Toward the operational identification of adverse drug reactions, Clinical Pharmacology and Therapeutics, 21, pp. 247-254, (1977)
[18]  
Klein H.O., Becker B., DiSegni E., Kaplinski E., Asystole produced by the combination of amiodarone and digoxin, American Heart Journal, 113, pp. 399-400, (1987)
[19]  
Kwoh C.K., Feinstein A.R., Rates of sensitivity reactions to aspirin: problems in interpreting the data, Clinical Pharmacology and Therapeutics, 40, pp. 494-505, (1986)
[20]  
Lakshmanan M.C., Hershey C.O., Breslau D., Hospital admissions caused by iatrogenic disease, Archives of Internal Medicine, 146, pp. 1931-1934, (1986)